Michael Parkins
Michael Parkins
Verified email at - Homepage
Cited by
Cited by
Multidrug Efflux Pumps: Expression Patterns and Contribution to Antibiotic Resistance in Pseudomonas aeruginosa Biofilms
TR De Kievit, MD Parkins, RJ Gillis, R Srikumar, H Ceri, K Poole, ...
Antimicrobial agents and chemotherapy 45 (6), 1761-1770, 2001
A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients
CD Sibley, MD Parkins, HR Rabin, K Duan, JC Norgaard, MG Surette
Proceedings of the National Academy of Sciences 105 (39), 15070-15075, 2008
Pseudomonas aeruginosa GacA, a factor in multihost virulence, is also essential for biofilm formation
MD Parkins, H Ceri, DG Storey
Molecular microbiology 40 (5), 1215-1226, 2001
Discerning the Complexity of Community Interactions Using a Drosophila Model of Polymicrobial Infections
CD Sibley, K Duan, C Fischer, MD Parkins, DG Storey, HR Rabin, ...
PLoS pathogens 4 (10), e1000184, 2008
Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections
MD Parkins, DM Sabuda, S Elsayed, KB Laupland
Journal of antimicrobial chemotherapy 60 (3), 613-618, 2007
Epidemiology, biology, and impact of clonal Pseudomonas aeruginosa infections in cystic fibrosis
MD Parkins, R Somayaji, VJ Waters
Clinical microbiology reviews 31 (4), 10.1128/cmr. 00019-18, 2018
Culture enriched molecular profiling of the cystic fibrosis airway microbiome
CD Sibley, ME Grinwis, TR Field, CS Eshaghurshan, MM Faria, SE Dowd, ...
PloS one 6 (7), e22702, 2011
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
MD Parkins, RA Floto
Journal of Cystic Fibrosis 14 (3), 293-304, 2015
Phenotypic heterogeneity of Pseudomonas aeruginosa populations in a cystic fibrosis patient
ML Workentine, CD Sibley, B Glezerson, S Purighalla, JC Norgaard-Gron, ...
PloS one 8 (4), e60225, 2013
Incidence, risk factors, and outcomes for Enterococcus spp. blood stream infections: a population-based study
EO Billington, SH Phang, DB Gregson, JDD Pitout, T Ross, DL Church, ...
International Journal of Infectious Diseases 26, 76-82, 2014
Population‐Based Epidemiological Study of Infections Caused by Carbapenem‐Resistant Pseudomonas aeruginosa in the Calgary Health Region: Importance of …
KB Laupland, MD Parkins, DL Church, DB Gregson, TJ Louie, JM Conly, ...
Journal of Infectious Diseases 192 (9), 1606-1612, 2005
Population-Based Study of the Epidemiology and the Risk Factors for Pseudomonas aeruginosa Bloodstream Infection
MD Parkins, DB Gregson, JDD Pitout, T Ross, KB Laupland
Infection 38, 25-32, 2010
The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature review
MD Parkins, CD Sibley, MG Surette, HR Rabin
Pediatric pulmonology 43 (5), 490-497, 2008
Incidence and risk factors for pulmonary exacerbation treatment failures in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa
MD Parkins, JC Rendall, JS Elborn
Chest 141 (2), 485-493, 2012
Cystic fibrosis gene modifier SLC26A9 modulates airway response to CFTR-directed therapeutics
LJ Strug, T Gonska, G He, K Keenan, W Ip, PY Boelle, F Lin, N Panjwani, ...
Human molecular genetics 25 (20), 4590-4600, 2016
Antimicrobial susceptibility testing (AST) and associated clinical outcomes in individuals with cystic fibrosis: a systematic review
R Somayaji, MD Parkins, A Shah, SL Martiniano, MM Tunney, JS Kahle, ...
Journal of Cystic Fibrosis 18 (2), 236-243, 2019
The genus Prevotella in cystic fibrosis airways
TR Field, CD Sibley, MD Parkins, HR Rabin, MG Surette
Anaerobe 16 (4), 337-344, 2010
Sputum microbiota is predictive of long-term clinical outcomes in young adults with cystic fibrosis
N Acosta, A Heirali, R Somayaji, MG Surette, ML Workentine, CD Sibley, ...
Thorax 73 (11), 1016-1025, 2018
Population-based assessment of the incidence, risk factors, and outcomes of anaerobic bloodstream infections
JT Ngo, MD Parkins, DB Gregson, JDD Pitout, T Ross, DL Church, ...
Infection 41, 41-48, 2013
Changing epidemiology and clinical issues arising in an ageing cystic fibrosis population
MD Parkins, VM Parkins, JC Rendall, S Elborn
Therapeutic advances in respiratory disease 5 (2), 105-119, 2011
The system can't perform the operation now. Try again later.
Articles 1–20